Morgan Stanley Re Walk Robotics Ltd. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.63 - $0.83 $11,035 - $14,539	17,517 New	17,517 $13,000
Q4 2023 Feb 13, 2024	SELL	$0.63 - $0.83 $17 - $23	-28 Reduced 0.16%	17,517 $13,000
Q3 2023 Nov 15, 2023	BUY	$0.6 - $0.85 $10,200 - $14,450	17,000 Added 3119.27%	17,545 $13,000
Q1 2023 May 15, 2023	BUY	$0.64 - $0.88 $330 - $454	517 Added 1846.43%	545 $0
Q4 2022 Feb 14, 2023	SELL	$0.71 - $1.0 $947 - $1,335	-1,335 Reduced 97.95%	28 $0
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.12 $1,144 - $1,490	1,331 Added 4159.38%	1,363 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.2 - $1.62 $11,073 - $14,949	-9,228 Reduced 99.65%	32 $0
Q3 2021 Nov 15, 2021	BUY	$1.25 - $2.59 $11,575 - $23,983	9,260 New	9,260 $14,000

17.6K

Ticker RWLK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 62,823,200
Market Cap $319M
Description
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by para...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.